JPS62156559A - Preparation of reagent for liquid chromatography and liquid chromatography - Google Patents
Preparation of reagent for liquid chromatography and liquid chromatographyInfo
- Publication number
- JPS62156559A JPS62156559A JP29931485A JP29931485A JPS62156559A JP S62156559 A JPS62156559 A JP S62156559A JP 29931485 A JP29931485 A JP 29931485A JP 29931485 A JP29931485 A JP 29931485A JP S62156559 A JPS62156559 A JP S62156559A
- Authority
- JP
- Japan
- Prior art keywords
- adam
- pgs
- reagent
- liquid chromatography
- deriv
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は、プロスタグランディン類を液体クロマトグラ
フィーで分析するために用いる試薬の調製法およびその
試薬を用いた分析方法に関する。DETAILED DESCRIPTION OF THE INVENTION [Field of Industrial Application] The present invention relates to a method for preparing a reagent used for analyzing prostaglandins by liquid chromatography and an analysis method using the reagent.
プロスタグランディン(P G)類は、生理作用上重要
な役割をするものとして臨床的に注目されている物質で
ある。PG類としては、PGE、。Prostaglandins (PGs) are substances that have attracted clinical attention as they play an important physiological role. Examples of PGs include PGE.
P’GEz 、PGEa 、PGFti、PGFzm。P’GEz, PGEa, PGFti, PGFzm.
PGFg、<、6−ケドーP G F tヴ、トロンボ
キサン(TX)Bz 、PGエンドペルオキシド、プロ
スタサイクリン(PGIz)など約20種が知られてい
る。Approximately 20 types are known, including PGFg, <, 6-kedoPGFtv, thromboxane (TX)Bz, PG endoperoxide, and prostacyclin (PGIz).
このようなPG類は、そのままの形では蛍光検出器で測
定することが困難であるので、あらかじめカルボキシル
基用蛍光プレラベル試薬と反応させ、反応生成物を液体
クロマトグラフで分離分析する試みがなされている(例
えば特開昭58−108457)。蛍光プレラベル試薬
の代表的なものは、9−アンスリルジアゾメタン(Ar
)AM)であるが、実用上の質点があるため、この方法
はまだ一般化寝れていない。Since it is difficult to measure such PGs in their original form with a fluorescence detector, attempts have been made to react them with a fluorescent pre-label reagent for carboxyl groups in advance and separate and analyze the reaction products using liquid chromatography. (For example, Japanese Patent Application Laid-Open No. 58-108457). A typical fluorescent prelabel reagent is 9-anthryldiazomethane (Ar
) AM) However, this method has not yet been generalized because of the practical mass points.
PG類は、生体試料(例えばヒトの血清)中に極めて微
量にしか含有されていないため、高感度検出が要求され
る。Since PGs are contained in extremely small amounts in biological samples (eg, human serum), highly sensitive detection is required.
一方、合成されたADAM試薬は多くの不純物を含んで
おり、使用時に粉末状のADAMを有機溶媒で溶解して
PG類と反応させ液体クロマ1〜グラフによって分離分
析しても、PG′E1のADAM誘導体とそれら不純物
との分別が困難であった。On the other hand, the synthesized ADAM reagent contains many impurities, and even if powdered ADAM is dissolved in an organic solvent and reacted with PGs during use and separated and analyzed using liquid chroma 1~graph, PG'E1 It was difficult to separate ADAM derivatives from these impurities.
従って、ADAMと反応させる前にPG類の抽出濃縮に
多大な労力を費さざるを得す、実用的な機敏分析は困難
であった。Therefore, it has been difficult to carry out practical and quick analysis, requiring a great deal of effort to extract and concentrate PGs before reacting them with ADAM.
本発明の目的は、9−アンスリルジアゾメタンの不純物
を低減してプロスタグランディン類の実用的なit分祈
を可能にする試薬調製法を提供することにあり、また、
そのようにして調製した試薬を用いて液体クロマトグラ
フィーを行う分析方法を提供することにある。An object of the present invention is to provide a reagent preparation method that reduces impurities in 9-anthryldiazomethane and enables the practical preparation of prostaglandins.
The object of the present invention is to provide an analytical method for performing liquid chromatography using the reagent thus prepared.
A D A Mは、PG類のカルボキシル基と次式のよ
うに反応して誘導体を形成するので、この誘導体を液体
クロマトグラフで成分分離し蛍光光度測定する。ここで
はPGE2の例を示す。ADAM reacts with the carboxyl group of PGs as shown in the following formula to form a derivative, and the components of this derivative are separated using a liquid chromatograph and the fluorescence intensity is measured. Here, an example of PGE2 is shown.
ADAMは、高温下あるいは高圧力下で処理すると大幅
に活性が減少する。そこで、本発明では、液体クロマト
グラフィー用試薬の1!4製を低温で行ない、かつ、高
圧力をかけない。When ADAM is processed at high temperatures or pressures, its activity is significantly reduced. Therefore, in the present invention, liquid chromatography reagents are prepared at low temperatures and high pressure is not applied.
本発明の試薬調製法は、9−アンスリルジアゾメタンを
有機溶媒に溶解し、マイナス10℃以下に冷却したのち
、非加圧下で冷却時の不溶解成分を除去し、精製された
9−アンスリルジアゾメタン溶液を回収することを特徴
とする。In the reagent preparation method of the present invention, 9-anthryl diazomethane is dissolved in an organic solvent, cooled to -10°C or lower, and undissolved components upon cooling are removed under no pressure to obtain purified 9-anthryl diazomethane. It is characterized by recovering a diazomethane solution.
また、本発明に基づくPG類の分析方法は、9−アンス
リルジアゾメタンを有機溶媒に溶解し。Moreover, in the method for analyzing PGs based on the present invention, 9-anthryldiazomethane is dissolved in an organic solvent.
マイナス10℃以下の冷却状態で不溶解成分を除去して
溶液状試薬を得、この溶液状試薬とプロスタグランディ
ン類を含む試料とを混合し、この混合によって上記9−
アンスリルジアゾメタンの誘導体を生じた反応液を形成
し、この反応液を液体クロマトグラフ装置の分離カラム
に導入して成分分離し、上記分離カラムからの溶出液を
蛍光光度測定することを特徴とする。A solution-like reagent is obtained by removing insoluble components in a cooled state at -10°C or lower, and this solution-like reagent is mixed with a sample containing prostaglandins.
It is characterized by forming a reaction solution that has produced an anthryl diazomethane derivative, introducing this reaction solution into a separation column of a liquid chromatography device to separate the components, and measuring the eluate from the separation column by fluorescence photometry. .
上述の非加圧下での不溶解成分の除去の態様の1つは、
粗い充填剤を充填したカラム内にADAM溶液を自然流
下させ液を回収する。他の態様は、始動時および停止時
の速度変化をゆるやかにして遠心分離し、上清液を回収
する。One of the aspects of the above-mentioned removal of undissolved components under non-pressurized conditions is
The ADAM solution is allowed to flow down by gravity into a column packed with a coarse packing material, and the liquid is collected. In another embodiment, the centrifugation is performed by slowing down the speed changes during startup and shutdown, and the supernatant liquid is collected.
ADAM試薬で誘導体化されたPG類は液体クロマトグ
ラフ装置に導入されるが、このときの液体クロマトグラ
フィーは、逆相分配法が適している。The PGs derivatized with the ADAM reagent are introduced into a liquid chromatography device, and a reverse phase distribution method is suitable for the liquid chromatography at this time.
本発明では、ADAM溶解液を高温および高圧力を加え
ることなく処理して調製するので、ADAMの分解が防
止される。本発明では、ADAM溶解液がマイナス10
℃以下ではADAM自体と不純物との間に溶解度の差が
著しくなることを利用する。In the present invention, since the ADAM solution is prepared by processing without applying high temperature and high pressure, decomposition of ADAM is prevented. In the present invention, the ADAM solution is minus 10
This method utilizes the fact that at temperatures below .degree. C., there is a significant difference in solubility between ADAM itself and impurities.
誘導体生成反応後、液体クロマトグラフィーにより分離
分析すると、未反応のADAMがPG類の流出に先行し
て分離カラムから流出するので、未反応ADAMとPG
類を分別することができる。After the derivative formation reaction, when separated and analyzed by liquid chromatography, unreacted ADAM flows out from the separation column before PGs flow out, so unreacted ADAM and PG are separated.
It is possible to separate the types.
PG類との分離が困難な不純物は、誘導体化前に除去さ
れるので、PG誘導体の微量検出が可能となる。Since impurities that are difficult to separate from PGs are removed before derivatization, trace amounts of PG derivatives can be detected.
まずADAM試薬の調製方法について説明する。 First, the method for preparing the ADAM reagent will be explained.
市販されている粉末状ADAM5mgをメチルアルコー
ル5 m Q、に溶解する。このとき、ADAMは難溶
であるので、超音波をかけながら溶解する(操作1)。5 mg of commercially available powdered ADAM is dissolved in 5 mQ of methyl alcohol. At this time, since ADAM is hardly soluble, it is dissolved while applying ultrasonic waves (operation 1).
次に溶解液を、マイナス20℃に冷却した状態で、24
時間静置する。これによりゲル状もしくはシャーベット
状の析出物が出願する。このゲル状析出物には不純物が
多量に含まれ、ADAMはわずかじか含まれない。そこ
で、上澄液をピペッタ−を用いて静かに採取する。採取
できる液量は約4mQ、である(操作2)。この状態で
もかなり妨害共存物質が除去されるが、マイナス20℃
では懸濁状態が幾分残る。Next, the solution was cooled to -20℃ for 24 hours.
Let stand for a while. This results in a gel-like or sherbet-like precipitate. This gel-like precipitate contains a large amount of impurities and only a small amount of ADAM. Then, gently collect the supernatant using a pipettor. The amount of liquid that can be collected is approximately 4 mQ (operation 2). Even in this state, a considerable amount of interfering coexisting substances are removed, but at -20℃
A somewhat suspended state remains.
次に注射器外筒状のプラスチック製の管(内容積5〜1
0 m Q )の出口端部にグラスウールを詰めてフィ
ルターとし、そのグラスウール層の上にバイオビーズS
X2 (バイオラッド社製)を3mQ充填して吸着カラ
ムを形成する。この吸着カラムをスタンドに保持し、ピ
ペッタに吸入されている上澄液を吸着カラムの上方から
静かに滴下する。吸着カラムから流出する液の内、最初
の1mQは廃棄し、その後の流出液を容器に採取する。Next, insert a syringe-shaped plastic tube (inner volume: 5 to 1
0 m Q) was filled with glass wool at the outlet end to form a filter, and biobeads S were placed on top of the glass wool layer.
An adsorption column is formed by filling 3 mQ of X2 (manufactured by Bio-Rad). This adsorption column is held on a stand, and the supernatant liquid drawn into the pipettor is gently dripped from above the adsorption column. The first 1 mQ of the liquid flowing out from the adsorption column is discarded, and the remaining liquid is collected in a container.
回収される液量は約2〜2.5mu である(操作3
)。このような操作によってADAMはほとんど吸着さ
れず、不溶解成分が濾過および吸着される。精製はこれ
で完了するので、この回収液であるAI)AM試薬をマ
イナス20℃で保存する。この試薬は約1週間使用する
ことができる。この試薬液に析出物が生じた場合には、
上述の操作3を実行して精製することにより使用に供す
ることができる。The amount of liquid recovered is approximately 2-2.5 mu (operation 3).
). By such operation, ADAM is hardly adsorbed, and insoluble components are filtered and adsorbed. Since the purification is now complete, this recovered solution, the AI)AM reagent, is stored at -20°C. This reagent can be used for about one week. If a precipitate occurs in this reagent solution,
It can be used by performing the above-mentioned operation 3 and purifying it.
PG類の蛍光プレラベル化反応に使用する際には、上述
の試薬液にメチルアルコールを加えて5倍に希釈する。When used in the fluorescent prelabeling reaction of PGs, methyl alcohol is added to the above-mentioned reagent solution to dilute it 5 times.
一連の操作で使用するメチルアルコールは窒素ガスを通
気してあらかじめ溶存する酸素を除去しておく。処理操
作の間も窒素ガスによる全酸素を行った方が良好な結果
をもたらす。Methyl alcohol used in a series of operations is bubbled with nitrogen gas to remove dissolved oxygen in advance. Even during the treatment operation, it is better to use nitrogen gas for total oxygenation, which gives better results.
ヒト血清中のPGlffを測定しようとする場合には、
血清をあらかじめ前処理しておくのが好ましい。前処理
は、まず、血清試料1mQを、セントリフローCF25
(アミコン社製)を用い4℃。When trying to measure PGlff in human serum,
Preferably, the serum is pretreated. For pretreatment, first, 1 mQ of serum sample was transferred to Centriflow CF25
(manufactured by Amicon) at 4°C.
10000にて限外濾過する。この濾過にクロロホルム
1mflを加えて3分間振とうし、PG類をクロロホル
ム層に抽出する。約10分間静置したのち、試験管にク
ロロホルム層を採取する。この際、試験管には窒素ガス
を吹き込む。この試験管を約50℃のウォーターバスに
浸漬し、加温して蒸発乾固する(操作4)。Ultrafilter at 10,000. Add 1 mfl of chloroform to this filtration and shake for 3 minutes to extract PGs into the chloroform layer. After leaving it to stand for about 10 minutes, collect the chloroform layer in a test tube. At this time, nitrogen gas is blown into the test tube. This test tube is immersed in a water bath at about 50° C. and heated to evaporate to dryness (operation 4).
PG類のプレラベル化反応は、操作3で得たADAM試
薬を5倍希釈した液と、操作4で得た乾固残留物との間
で行う。すなわち、操作4の乾固残留物に希釈AI)A
M試薬を50μQ加えて、残留物を溶解するとともに1
時間反応させ、PG類のADAM誘導体を生成させる(
操作5)。この反応液を液体クロマトグラフに導入して
成分分離する。The pre-labeling reaction of PGs is performed between the 5-fold dilution of the ADAM reagent obtained in Step 3 and the dried residue obtained in Step 4. That is, dilute AI)A to the dry residue of step 4.
Add 50 μQ of M reagent to dissolve the residue and add 1
React for a period of time to generate ADAM derivatives of PGs (
Operation 5). This reaction solution is introduced into a liquid chromatograph to separate the components.
液体クロマトグラフの分離カラムは、大きさが内径4+
mm、長さが150mmのものを使用した。カラム充填
剤として粒径が3μmのオクタデシルシラン(OI′)
S)を用いた0分離カラムに流通させる溶離液は、水2
5%とメチルアルコール75%の容量比の混合液を、1
m m / lll1nの流量で流した。検出器とし
て蛍光光度計を用い、励起波長を365nmに設定し、
蛍光波長を412nmに設定した。The separation column for liquid chromatography has an inner diameter of 4+
mm, and the length was 150 mm. Octadecylsilane (OI') with a particle size of 3 μm as a column packing material
The eluent to be passed through the 0 separation column using water 2
A mixture of 5% and 75% methyl alcohol by volume was added to 1
It was flowed at a flow rate of mm/lll1n. Using a fluorometer as a detector and setting the excitation wavelength to 365 nm,
The fluorescence wavelength was set at 412 nm.
このようにして得たクロマトグラフの例を、第1図に示
す。ピークの肩に付した数字は溶出時間(リテンション
タイム)を分単位で表わしたものである。第1図の測定
例は、ヒトの血清を上述した操作に従って処理し、反応
液を5μQ注入したときのクロマトグラムである。第1
図中、AはT X B zのピークであり、BはP G
D 2とPGEzの混合ピークであり、CはP G
E 1のピークであり、Dは6−ケドーP G F x
<のピークである。これらのPG類は注入に相当する血
清100μΩ中にそれぞれ数ピコグラム(p g)含有
されているにすぎないが、本漬によればこのような微量
でも検出可能であり、従来の10倍以上の高感度で測定
できる。An example of the chromatograph thus obtained is shown in FIG. The number on the shoulder of the peak represents the elution time (retention time) in minutes. The measurement example shown in FIG. 1 is a chromatogram obtained when human serum was processed according to the procedure described above and 5 μQ of the reaction solution was injected. 1st
In the figure, A is the peak of T X B z, and B is the peak of P G
It is a mixed peak of D2 and PGEz, and C is P G
It is the peak of E 1, and D is 6-kedo PG F x
This is the peak of <. These PGs are contained in only a few picograms (pg) of each in 100 μΩ of serum equivalent to injection, but according to Honzuke, even such a small amount can be detected, and the detection rate is more than 10 times that of conventional methods. Can be measured with high sensitivity.
第2図および第3図は、ADAM試薬だけを液体クロマ
トグラフで同様の条件で測定した試薬ブランクのクロマ
トグラムである。第2図は上述の操作1で得た精製前の
ADAM溶液をメタルアルコールで5倍希釈したものを
液体クロマトグラフに5μQ注入したときのクロマトグ
ラムであり、20分以降でも多数のピークが出現してい
る。第3図は上述の操作3で得た精製後のADAM試薬
液を5倍希釈したものを5μQ注入したときのクロマト
グラムである。不純物成分に基づくピークが少なく、2
6分以降はほとんどピークが出現していない。このよう
に、ADAM試薬由来の不純物は、本漬により大幅に減
少される。FIGS. 2 and 3 are reagent blank chromatograms in which only the ADAM reagent was measured using a liquid chromatograph under similar conditions. Figure 2 is a chromatogram obtained when 5 μQ of the unpurified ADAM solution obtained in step 1 above diluted with metal alcohol was injected into a liquid chromatograph, and many peaks appeared even after 20 minutes. ing. FIG. 3 is a chromatogram obtained when 5 μQ of the purified ADAM reagent solution obtained in Step 3 above was diluted 5 times and injected. Fewer peaks due to impurity components, 2
Almost no peaks appear after 6 minutes. In this way, impurities derived from the ADAM reagent are significantly reduced by this soaking.
上述の実施例では、操作2の後懸濁物を低温常圧下で吸
着カラムを用いて除去したが、操作2以降のS濁物の除
去は、前記した遠心分離法を適用し上清液を採取する方
法によって除去することもできる。In the above example, the suspended matter after Step 2 was removed using an adsorption column at low temperature and normal pressure, but the removal of the S turbidity after Step 2 was performed by applying the above-mentioned centrifugation method and removing the supernatant. It can also be removed by collecting it.
精製したADAM試薬は、PC類の分析に用いられる他
、従来困難とされたカーボン数が16以下の有機酸の分
析にも適用可能となる。In addition to being used for the analysis of PCs, the purified ADAM reagent can also be applied to the analysis of organic acids with carbon numbers of 16 or less, which has been considered difficult in the past.
本発明によれば、ADAM試薬中の不純物を大幅に低減
できるので、PG類の微量分析が可能になるという効果
が奏せられる。According to the present invention, since impurities in the ADAM reagent can be significantly reduced, it is possible to perform trace analysis of PGs.
第1図は本発明に基づいて11)lI量のPG類を含む
実試料を測定したクロマトグラムの例を示す図、第2図
は精製前のADAMの試薬ブランクを示すクロマトグラ
ム例、第3図は精製後のADAMの試薬ブランクを示す
クロマトグラム例である。Figure 1 is a diagram showing an example of a chromatogram obtained by measuring an actual sample containing 11) lI amount of PGs based on the present invention, Figure 2 is an example of a chromatogram showing a reagent blank of ADAM before purification, and Figure 3 The figure is an example chromatogram showing a reagent blank of ADAM after purification.
Claims (1)
マイナス10℃以下の冷却状態で不溶解成分を除去して
溶液状試薬を得、この溶液状試薬とプロスタグランデイ
ン類を含む試料とを混合し、この混合によつて上記9−
アンスリルジアゾメタンの誘導体を生じた反応液を形成
し、この反応液を液体クロマトグラフ装置の分離スラム
に導入して成分分離し、上記分離カラムからの溶出液を
蛍光光度測定することを特徴とする液体クロマトグラフ
ィー。 2、9−アンスリルジアゾメタンを有機溶媒に溶解し、
マイナス10℃以下に冷却したのち、非加圧下で冷却時
の不溶解成分を除去し、精製された9−アンスリルジア
ゾメタン溶液を回収することを特徴とする液体クロマト
グラフィー用試薬調製法。[Claims] 1,9-anthryldiazomethane is dissolved in an organic solvent,
A solution-like reagent is obtained by removing insoluble components in a cooled state of -10°C or less, and this solution-like reagent is mixed with a sample containing prostaglandins, and by this mixing, the above-mentioned 9-
It is characterized by forming a reaction solution that has produced an anthryl diazomethane derivative, introducing this reaction solution into a separation slum of a liquid chromatography device to separate the components, and measuring the eluate from the separation column by fluorescence photometry. liquid chromatography. Dissolving 2,9-anthryldiazomethane in an organic solvent,
1. A method for preparing a reagent for liquid chromatography, which comprises cooling to -10° C. or below, removing insoluble components during cooling without pressure, and recovering a purified 9-anthryldiazomethane solution.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP29931485A JPS62156559A (en) | 1985-12-27 | 1985-12-27 | Preparation of reagent for liquid chromatography and liquid chromatography |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP29931485A JPS62156559A (en) | 1985-12-27 | 1985-12-27 | Preparation of reagent for liquid chromatography and liquid chromatography |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS62156559A true JPS62156559A (en) | 1987-07-11 |
Family
ID=17870932
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP29931485A Pending JPS62156559A (en) | 1985-12-27 | 1985-12-27 | Preparation of reagent for liquid chromatography and liquid chromatography |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS62156559A (en) |
-
1985
- 1985-12-27 JP JP29931485A patent/JPS62156559A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SU1356966A3 (en) | Method of separaing methyl esters of fatty and resin acids,and isolating them from esterified tall oil | |
CN112345651B (en) | Method for determining content of halogenated acid in chloral hydrate or preparation thereof | |
Erdtmansky et al. | Gas-liquid chromatographic electron capture determination of some monosubstituted guanido-containing drugs | |
Westenberg et al. | Rapid and sensitive liquid chromatographic determination of carbamazepine suitable for use in monitoring multiple-drug anticonvulsant therapy | |
Edlund | Determination of clonidine in human plasma by glass capillary gas chromatography with electron-capture detection | |
Emteborg et al. | Quality control of a recently developed analytical method for the simultaneous determination of methylmercury and inorganic mercury in environmental and biological samples | |
JPS62156559A (en) | Preparation of reagent for liquid chromatography and liquid chromatography | |
WO2005093407A1 (en) | Method and apparatus for pre-treating polynuclear aromatic hydrocarbon before analyzing | |
CN106093253B (en) | The assay method of benzo [a] pyrene in sample-pretreating method and cigarette smoke for measuring benzo in cigarette smoke [a] pyrene | |
CN110003035B (en) | Stable isotope labeled 3-ethyl aminobenzoate-D5And method for preparing the same | |
CN113740198A (en) | Method for determining yellow vaseline content in Mayinglong musk hemorrhoid ointment | |
CN110687224B (en) | Method for measuring triptolide A in tripterygium wilfordii medicinal material and tripterygium wilfordii multi-glycoside tablet prepared from tripterygium wilfordii medicinal material | |
JPS6188148A (en) | Pretreatment of catecholamine for high-speed liquid chromatography using fluorescent spectroscopic detector | |
CN115792007A (en) | Method for determining content of impurity aluminum element in fat emulsion injection by high performance liquid chromatography | |
Chilcote | Column-chromatographic analysis of naturally fluorescing compounds: III. Rapid analysis of serotonin and tryptamine | |
JP3144066B2 (en) | Determination of boron in sulfuric acid | |
JPS63193039A (en) | Method for analyzing medicinal components of ginseng | |
CN111157655B (en) | Method for detecting organochlorine pesticide in environmental water by combining dispersed solid phase extraction with GC (gas chromatography) | |
JPS63149561A (en) | Analysis of prostaglandin | |
CN115326984B (en) | Method for measuring content of baicalin metal complex by HPLC (high Performance liquid chromatography) | |
JPH0126506B2 (en) | ||
CN112816578B (en) | Detection method of amino-containing small molecule mushroom toxin and kit | |
CN107029453A (en) | A kind of 17 α hydroxyprogesterone molecularly imprinted solid phase extraction columns and preparation method thereof and the method for detecting 17 α hydroxyprogesterones | |
JPH06258311A (en) | Reaction medium of 1,2-diphenyl ethylenediamine with catechol amines | |
SU1422074A1 (en) | Method of preparing samples-radiators for x-ray fluorescent analysis of metals |